Combination CDC-like kinase inhibition (CLK)/Dual-specificity tyrosine-regulated kinase (DYRK) and taxane therapy in <i>CTNNB1</i>-mutated endometrial cancer.

Corr, Bradley R; Moroney, Marisa R; Woodruff, Elizabeth; Watson, Zachary L; Jordan, Kimberly R; Danhorn, Thomas; Bailey, Courtney; Wolsky, Rebecca J; Bitler, Benjamin G

Combination CDC-like kinase inhibition (CLK)/Dual-specificity tyrosine-regulated kinase (DYRK) and taxane therapy in CTNNB1-mutated endometrial cancer.

Corr, Bradley R; Moroney, Marisa R; Woodruff, Elizabeth; Watson, Zachary L; Jordan, Kimberly R; Danhorn, Thomas; Bailey, Courtney; Wolsky, Rebecca J; Bitler, Benjamin G.

Affiliation

Corr BR; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Colorado School of Medicine, Aurora, Colorado, USA.
Moroney MR; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Colorado School of Medicine, Aurora, Colorado, USA.
Woodruff E; Division of Reproductive Sciences, Department of Obstetrics and Gynecology, University of Colorado School of Medicine, Aurora, Colorado, USA.
Watson ZL; Division of Reproductive Sciences, Department of Obstetrics and Gynecology, University of Colorado School of Medicine, Aurora, Colorado, USA.
Jordan KR; Department of Immunology and Microbiology, University of Colorado School of Medicine, Aurora, Colorado, USA.
Danhorn T; University of Colorado Cancer Center, University of Colorado School of Medicine, Aurora, Colorado, USA; Department of Pharmacology, University of Colorado School of Medicine, Aurora, Colorado, USA.
Bailey C; Division of Reproductive Sciences, Department of Obstetrics and Gynecology, University of Colorado School of Medicine, Aurora, Colorado, USA.
Wolsky RJ; Department of Pathology, University of Colorado School of Medicine, Aurora, Colorado, USA.
Bitler BG; Division of Reproductive Sciences, Department of Obstetrics and Gynecology, University of Colorado School of Medicine, Aurora, Colorado, USA.